


Ask a doctor about a prescription for APEL 600 mg FILM-COATED TABLETS
Leaflet:information for the user
Apel 600 mg film-coated tablets EFG
linezolid
Read the entire leaflet carefully before starting to use this medication,as it contains important information for you.
Contents of the leaflet
5 Conservation of Apel
Apel is an antibiotic of the oxazolidinone group that acts by preventing the growth of certain bacteria (germs) that cause infections.
Antibiotics are used to treat bacterial infections and are not effective against viral infections such as the flu or the common cold.
It is essential that you follow the instructions regarding dosage, administration, and treatment duration indicated by your doctor.
Do not store or reuse this medication. If you have any leftover antibiotic after completing treatment, return it to the pharmacy for proper disposal. Do not throw away medications down the drain or in the trash.
It is used to treat pneumonia and certain skin or subcutaneous infections. Your doctor will have decided if Apel is suitable for treating your infection.
Do not take Apel:
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to use this medication.
Linezolid may not be suitable for you if you answer yesto any of the following questions. In that case, inform your doctor, as they will need to monitor your overall health and blood pressure before and during treatment or may decide that another treatment is better for you. Ask your doctor if you are unsure if any of these categories apply to your case.
The use of certain medications, including antidepressants and opioids, along with Apel may cause serotonin syndrome, a potentially life-threatening condition (see section 2 "Other medications and Apel" and section 4).
Be careful with Apel:
Inform your doctor before taking this medication if:
Inform your doctor immediately if the following appear during treatment:
Taking Apelwithother medications
Occasionally, linezolid may interact with certain medications and produce side effects such as changes in blood pressure, body temperature, or heart rate.
Inform your doctor if you are taking or have taken in the last 2 weeksthe following medications, as you should not take linezolid if you are still taking them or have taken them recently (see also section 2 "Do not take Apel"):
Also, inform your doctor if you are taking the following medications. Your doctor may decide to treat you with linezolid, but they will need to assess your overall health and blood pressure before and during treatment. In other cases, your doctor may decide that another treatment is better for you.
Inform your doctor, pharmacist, or nurse if you are using or have recently used any other medication, even those purchased without a prescription.
Taking Apelwithfood, drinks, and alcohol
Pregnancy, breastfeeding, and fertility
The effect of linezolid on pregnant women is unknown. Therefore, pregnant women should not use linezolid unless advised by their doctor. If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
You should not breastfeed while taking linezolid because this medication passes into breast milk and could affect your baby.
Driving and using machines
Linezolid can cause dizziness or vision problems. If this happens, do not drive or use machines. Remember that if you are not feeling well, your ability to drive or use machines may be affected.
This medication contains less than 23 mg of sodium (1 mmol) per dose; it is essentially "sodium-free".
Adults
Always follow the administration instructions for the medication contained in this leaflet or as indicated by your doctor, pharmacist, or nurse. In case of doubt, ask your doctor, pharmacist, or nurse.
The recommended dose is one film-coated tablet (600 mg) twice a day (every 12 hours). You should swallow the film-coated tablet whole with a little water.
If you are on a dialysis program, you should take linezolid after each session.
The normal treatment duration is 10-14 days, but it may be extended up to 28 days. The safety and efficacy of this medication have not been established for treatment periods longer than 28 days. Your doctor will decide the duration of your treatment.
While taking linezolid, your doctor will perform periodic blood tests to monitor your blood count.
If you take linezolid for more than 28 days, your doctor should monitor your vision.
Use in children and adolescents
Linezolid is not normally used in children or adolescents (under 18 years).
If you take more Apel than you should
Inform your doctor or pharmacist immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Apel
Take the missed tablet as soon as you remember. Take the next tablet 12 hours later and continue taking the tablets every 12 hours. Do not take a double dose to make up for the missed dose.
If you interrupt treatment with Apel
It is essential that you only interrupt your treatment if your doctor advises you to do so. If you interrupt your treatment and the initial symptoms return, inform your doctor or pharmacist immediately.
If you have any other questions about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Inform your doctor, nurse, or pharmacist immediatelyif you notice any of the following side effects while being treated with linezolid:
The most serious side effects of linezolid (whose frequency is between parentheses) are:
There have been reports of numbness, tingling, or blurred vision in patients who have taken linezolid for more than 28 days. If you experience vision difficulties, consult your doctor as soon as possible.
Other side effects include:
Frequent(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
The following side effects have also been reported(unknown: frequency cannot be estimated from available data):
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are possible side effects not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es.
By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
This medication does not require special storage conditions.
Do not use this medication after the expiration date shown on the box after CAD. The expiration date is the last day of the month indicated.
Medications should not be thrown away down the drain or in the trash. Deposit the packaging and any unused medication in the pharmacy's SIGRE point. This will help protect the environment.
Composition of Apel
Appearance of the Product and Packaging Content
The film-coated tablets are white, oval, biconvex, flat on both sides with dimensions of 18 x 9 mm.
The packaging contains opaque PVC/PVDC-Alu blisters with 10, 14, 20, 24, 30, 50, 60 or 100 film-coated tablets.
Only some packaging sizes may be marketed.
Marketing Authorization Holder
Medochemie Ltd
1-10 Constantinoupoleos street
3011 Limassol,
Cyprus
Manufacturer
Medochemie Ltd, Factory AZ
2 Michael Erakleous Street,
Agios Athanassios Industrial Area,
Agios Athanassios, Limassol, 4101
Cyprus
For further information about this medicinal product, please contact the local representative of the marketing authorization holder:
Medochemie Iberia S.A., Branch in Spain
Avenida de las Águilas, nº 2 B; 5th floor, office 6,
28044 Madrid
SPAIN
Date of the last revision of thisleaflet:January 2025
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for APEL 600 mg FILM-COATED TABLETS – subject to medical assessment and local rules.